Overuse of levothyroxine in the United States
One of the most common prescription drugs in America – levothyroxine – is used by people with underactive thyroid glands, also known as hypothyroidism. However, a new study by Mayo Clinic researchers says the majority of people were initiated on levothyroxine for mild subclinical hypothyroidism or for no apparent thyroid dysfunction. These results , published in JAMA Internal Medicine, suggest significant overuse of levothyroxine. Mayo researchers and colleagues examined retrospective, deidentified case data using the OptumLabs Data… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - June 28, 2021 Category: Databases & Libraries Source Type: news

Levothyroxine Overprescribing Is Common, Consistent Over Time Levothyroxine Overprescribing Is Common, Consistent Over Time
A study detailing the consistent overuse of the thyroid replacement drug over a decade should be a ' call to action ' for doctors to stop treating patients with mild subclinical hypothyroidism, experts say.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - June 24, 2021 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

Claims Data Indicate Overuse of Levothyroxine in the U.S.
WEDNESDAY, June 23, 2021 -- Levothyroxine treatment is frequently initiated for mildly increased thyrotropin levels, with no change in the median thyrotropin level upon treatment initiation from 2008 to 2018, according to a research letter published... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 23, 2021 Category: Pharmaceuticals Source Type: news

Acella Pharmaceuticals, LLC, Issues Voluntary Nationwide Recall of Certain Lots of NP Thyroid ® (Thyroid Tablets, USP) Due to Sub Potency
Acella Pharmaceuticals, LLC, is voluntarily recalling certain lots listed in the Tables 1 and 2 below of 15-mg, 30-mg, 60-mg, 90-mg and 120-mg NP Thyroid ®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level. The products are being recalled because routine testing h (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 30, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Combo Thyroid Hormones as Good as Levothyroxine for Hypothyroidism Combo Thyroid Hormones as Good as Levothyroxine for Hypothyroidism
In a randomized, double-blind study of three common approaches to hypothyroidism, no significant differences in symptoms were reported.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - March 22, 2021 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

1 in 3 on Levothyroxine Take Meds That Interfere With Thyroid Tests 1 in 3 on Levothyroxine Take Meds That Interfere With Thyroid Tests
Around a third of older patients taking levothyroxine are prescribed other drugs that can interfere with thyroid function tests, shows the first study to examine this issue.Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - March 21, 2021 Category: Surgery Tags: Diabetes & Endocrinology News Source Type: news

1 in 3 Older Thyroid Patients Takes a Med That Can Interfere With Tests
THURSDAY, March 18, 2021 -- Nearly one-third of seniors who take thyroid hormone also take drugs known to interfere with tests of thyroid function, a new study finds. It ' s common for older adults to take a thyroid hormone (levothyroxine) to treat... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 18, 2021 Category: General Medicine Source Type: news

A Third Discontinuing Levothyroxine Have Normal Thyroid Levels A Third Discontinuing Levothyroxine Have Normal Thyroid Levels
Those with overt hypothyroidism are less likely to remain euthyroid than patients with subclinical disease, but many wind up restarting treatment.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 4, 2021 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Levothyroxine Sodium Products Enforcement of August 14, 2001 Compliance Date and Submission of New Applications
Procedural (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 1, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Thyquidity (Levothyroxine Sodium Oral Solution) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 11, 2020 Category: Drugs & Pharmacology Source Type: news

Thyquidity (Levothyroxine Sodium Oral Solution) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 10, 2020 Category: Drugs & Pharmacology Source Type: news

Euthyrox (Levothyroxine Sodium Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - November 25, 2020 Category: Drugs & Pharmacology Source Type: news

Lannett Launches Authorized Generic of Tirosint(R) (Levothyroxine Sodium Capsules)
Unique Oral Formulation of Levothyroxine Expands Thyroid Deficiency Product Portfolio PHILADELPHIA, Nov. 3, 2020 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it has commenced the launch of the auth... Biopharmaceuticals, Generics, Product Launch Lannnett, Tirosint, levothyroxine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 3, 2020 Category: Pharmaceuticals Source Type: news

Real-world Evidence from a Narrow Therapeutic Index Product (Levothyroxine) Reflects the Therapeutic Equivalence of Generic Drug Products
It appears that some prescribers are not aware that FDA bioequivalence standards ensure that generic products do not differ in safety, efficacy, or quality (including potency) from regulatory standards that govern brand-name products. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - October 2, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news